Development of Genistein Synthesis for Use as a Certified Reference Material

Q3 Pharmacology, Toxicology and Pharmaceutics
А. Жигалина, Г. Дударев, В. Тихонова, О. Ю. Стрелова, A. A. Zhigalina, Vladimir G. Dudarev, Viktoria V. Tikhonova, O. Strelova
{"title":"Development of Genistein Synthesis for Use as a Certified Reference Material","authors":"А. Жигалина, Г. Дударев, В. Тихонова, О. Ю. Стрелова, A. A. Zhigalina, Vladimir G. Dudarev, Viktoria V. Tikhonova, O. Strelova","doi":"10.33380/2305-2066-2021-10-4(1)-20-31","DOIUrl":null,"url":null,"abstract":"Introduction. The use of certified reference materials (CRMs) ensures metrological traceability and comparability of analysis results performed in different laboratories, by different analysts, at different times. Genistein is a promising substance with a wide spectrum of pharmacological action. genistein is widely used in dietary supplements. Development of regulatory documents for CRM of genistein will ensure the quality of drugs and dietary supplements.Aim. Aim of our study is to improve of the ways of synthesis and determination of spectrum characteristics of genistein for the certification of CRM.Materials and methods. We used synthetic genistein, (Ph.D. V. Yu. Kovtun SPC \"Pharmzashchita\") (sample № 1) and genistein synthesized and studied at the departments of pharmaceutical chemistry and chemical technology of medicinal substances SPCPU (sample № 2). Infrared spectra of genistein samples were collected on an FSM 1201 infrared Fourier spectrometer (OOO Infraspek, Russia) via KBr pellets technique. All the spectra were collected in the 4000–500 cm−1 range. The NMR (1H and 13C) measurements were performed with a BrukerAvance III NMR spectrometer (400 and 100 MHz) (Bruker, Germany) in DMSO-d6 solvent. Raman spectra were recorded by an ORTES-785TRS-2700 analytical Raman scattering system at a laser power of 100 mW (OPTEC JSC, Russia). Laser interaction time was 5, 10, 20 and 60 seconds. The results were processed using the software \"BWSpec 4.10_4\", USA. GC-MS was performed on an Agilent Technologies 7890A gas chromatograph (Agilent Technologies, USA) with a 7693 autoinjector and a Hewlett Packard 5975C mass selective detector.Results and discussion. The synthesis was carried out according to the developer's method. The stage \"removal of the alkyl protection\" has been improved. The spectra of the synthesis intermediate of genistein (biochanin A) correspond to the literature data. Samples of genistein were investigated by methods: MC and NMR 13С, 1Н. The structure of the investigated substance was confirmed; Raman and IR spectroscopy showed that the spectra of the samples do not differ from each other and there are no additional signals.Conclusion. The spectrum characteristics of samples of genistein were obtained by NMR, IR and Raman spectroscopy, which will be used in the regulatory documentation for CRM of genistein. All of this will make it possible to control the quality of medicines based on it and to identify substandard dietary supplements.","PeriodicalId":36465,"journal":{"name":"Drug Development and Registration","volume":" ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2021-12-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"2","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Drug Development and Registration","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.33380/2305-2066-2021-10-4(1)-20-31","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Pharmacology, Toxicology and Pharmaceutics","Score":null,"Total":0}
引用次数: 2

Abstract

Introduction. The use of certified reference materials (CRMs) ensures metrological traceability and comparability of analysis results performed in different laboratories, by different analysts, at different times. Genistein is a promising substance with a wide spectrum of pharmacological action. genistein is widely used in dietary supplements. Development of regulatory documents for CRM of genistein will ensure the quality of drugs and dietary supplements.Aim. Aim of our study is to improve of the ways of synthesis and determination of spectrum characteristics of genistein for the certification of CRM.Materials and methods. We used synthetic genistein, (Ph.D. V. Yu. Kovtun SPC "Pharmzashchita") (sample № 1) and genistein synthesized and studied at the departments of pharmaceutical chemistry and chemical technology of medicinal substances SPCPU (sample № 2). Infrared spectra of genistein samples were collected on an FSM 1201 infrared Fourier spectrometer (OOO Infraspek, Russia) via KBr pellets technique. All the spectra were collected in the 4000–500 cm−1 range. The NMR (1H and 13C) measurements were performed with a BrukerAvance III NMR spectrometer (400 and 100 MHz) (Bruker, Germany) in DMSO-d6 solvent. Raman spectra were recorded by an ORTES-785TRS-2700 analytical Raman scattering system at a laser power of 100 mW (OPTEC JSC, Russia). Laser interaction time was 5, 10, 20 and 60 seconds. The results were processed using the software "BWSpec 4.10_4", USA. GC-MS was performed on an Agilent Technologies 7890A gas chromatograph (Agilent Technologies, USA) with a 7693 autoinjector and a Hewlett Packard 5975C mass selective detector.Results and discussion. The synthesis was carried out according to the developer's method. The stage "removal of the alkyl protection" has been improved. The spectra of the synthesis intermediate of genistein (biochanin A) correspond to the literature data. Samples of genistein were investigated by methods: MC and NMR 13С, 1Н. The structure of the investigated substance was confirmed; Raman and IR spectroscopy showed that the spectra of the samples do not differ from each other and there are no additional signals.Conclusion. The spectrum characteristics of samples of genistein were obtained by NMR, IR and Raman spectroscopy, which will be used in the regulatory documentation for CRM of genistein. All of this will make it possible to control the quality of medicines based on it and to identify substandard dietary supplements.
染料木黄酮合成标准物质的研究进展
介绍认证标准物质(CRM)的使用确保了不同实验室、不同分析员在不同时间进行的分析结果的计量可追溯性和可比性。染料木黄酮是一种具有广泛药理作用的有前景的物质。染料木素广泛用于膳食补充剂。开发染料木黄酮CRM的监管文件将确保药物和膳食补充剂的质量。目标本研究的目的是改进染料木黄酮的合成方法和光谱特性测定方法,用于CRM认证。材料和方法。我们使用了合成染料木黄酮(Ph.D.V.Yu.KovtunSPC“Pharmzashchita”)(样品№ 1) 和染料木黄酮在药物化学和化学技术系合成并研究了药用物质SPCPU(样品№ 2) 。染料木素样品的红外光谱通过KBr颗粒技术在FSM 1201红外傅立叶光谱仪(OOO Infraspek,Russia)上收集。所有光谱都是在4000–500 cm−1的范围内收集的。NMR(1H和13C)测量用BrukerAvance III NMR光谱仪(400和100MHz)(Bruker,Germany)在DMSO-d6溶剂中进行。拉曼光谱由ORTES-785TRS-2700分析拉曼散射系统在100mW的激光功率下记录(OPTEC JSC,俄罗斯)。激光相互作用时间分别为5、10、20和60秒。使用软件“BWSpec 4.10_4”(美国)对结果进行处理。使用7693自动注射器和Hewlett-Packard 5975C质量选择检测器在安捷伦科技7890A气相色谱仪(安捷伦技术,美国)上进行GC-MS。结果和讨论。合成是根据显影剂的方法进行的。“去除烷基保护”阶段已得到改进。染料木素的合成中间体(生物炭素A)的光谱与文献数据一致。采用MC和NMR 13С,1Н对染料木素样品进行了研究。确认了所研究物质的结构;拉曼光谱和红外光谱表明,样品的光谱彼此没有差异,并且没有额外的信号。结论通过NMR、IR和拉曼光谱获得了染料木素样品的光谱特征,这些特征将用于染料木素CRM的监管文件中。所有这些都将使基于它的药物质量控制和确定不合格的膳食补充剂成为可能。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Drug Development and Registration
Drug Development and Registration Pharmacology, Toxicology and Pharmaceutics-Pharmaceutical Science
CiteScore
1.20
自引率
0.00%
发文量
61
审稿时长
8 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信